A Post-marketing Surveillance for Safety and Adherence to Treatment of Enbrel in Adults With Psoriatic Arthritis in Belgium.

Trial Profile

A Post-marketing Surveillance for Safety and Adherence to Treatment of Enbrel in Adults With Psoriatic Arthritis in Belgium.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jul 2015

At a glance

  • Drugs Etanercept (Primary)
  • Indications Psoriatic arthritis
  • Focus Adverse reactions
  • Acronyms PROVE
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 23 Jul 2015 Results published in the Clinical and Experimental Rheumatology.
    • 11 Jul 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
    • 15 Jun 2012 Planned end date changed from 1 May 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top